Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Topical finasteride (5-alpha-reductase inhibitor solution)
The same drug as oral finasteride, applied to the scalp — with a systemic-sparing claim that the pharmacokinetic data only partly supports.
Prescription medication — not a dietary supplement
Finasteride (topical) is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Finasteride (topical) doesn't have enough studies with structured effect-size data yet to pool a verdict. Browse the studies below for individual findings.
Most evidence is from high-quality meta-analyses and randomised trials published 2009–2025 with a typical study size of 77 participants.
Based on 8 studies · 1 meta-analysis · 5 RCTs · 794 total participants
Study base
8 studies indexedBy outcome
Every outcome below: Too few graded studies.
A 458-patient phase III with a double-dummy oral comparator is strong evidence for the hair endpoint, and two independent lines show topical matching oral on hair count. Held at 6.5 because the literature is small (the systematic review found seven articles), the supporting trials are single-centre and short, and the systemic-sparing rationale — the main reason to choose topical over oral — is only partly supported by the pharmacokinetic data.
3 trials ongoing or recruiting · 5 completed on ClinicalTrials.gov
1 of the completed trials have posted results
Registered trials show research momentum for Finasteride (topical), not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Nov 2026
Topical finasteride was developed to give oral finasteride’s hair effect while keeping the drug at the follicle. The phase III trial delivers on efficacy: target area hair count rose 20.2 against 6.7 hairs on placebo, numerically similar to oral. The exposure claim is the part to read carefully.
In the dedicated pharmacokinetic study, serum DHT fell 60-70% at the doses studied — and the systematic review found plasma DHT significantly reduced too.
Lower doses spared serum DHT more (24-26% at 100-200 µL) while still cutting scalp DHT roughly in half, so the trade is real but DOSE-DEPENDENT rather than automatic. Anyone choosing topical specifically to avoid systemic 5-alpha-reductase inhibition should know that.
Finasteride inhibits type II 5-alpha-reductase, cutting conversion of testosterone to dihydrotestosterone, the androgen that miniaturises follicles in androgenetic alopecia. Applied to the scalp, it reduced scalp DHT by roughly 70% at once-daily dosing.
The point of the topical route is to keep the drug local. In practice serum DHT still fell 60-70% at the studied doses, and only the lower doses (100-200 µL) held serum reduction to 24-26% while still halving scalp DHT.
Do not use or handle. Finasteride is teratogenic to a male fetus, and the topical route does not eliminate systemic absorption.
Discuss with a clinician. Serum DHT falls substantially even with topical use.
Using topical finasteride alongside an oral 5-alpha-reductase inhibitor stacks the same mechanism. Serum DHT already falls 60-70% with the topical alone at studied doses, so the combination offers no clear extra benefit and compounds systemic suppression.
The available source did not grade how severe these reactions were. This does not mean they were mild.
Finasteride (topical) has an evidence score of 6.5/10 — moderate evidence based on 8 indexed studies, including 1 meta-analysis. The same drug as oral finasteride, applied to the scalp — with a systemic-sparing claim that the pharmacokinetic data only partly supports. Representative study: PMID 41051009.
The best time to take Finasteride (topical) is in the evening. It can be taken on an empty stomach. Once-daily dosing gave the largest scalp DHT reduction (about 70%) in the pharmacokinetic study; evening application lets it sit undisturbed.
Finasteride (topical) should be used with caution — talk to a healthcare provider before taking it. Reported side effects include reduced libido or erectile difficulty (reported with systemic 5-ARI exposure), local scalp irritation or itching. How often they occur is not established for all of them. Use caution if any of these apply to you: Pregnancy — finasteride is teratogenic and can cause genital abnormalities in a male fetus; Women who are or may become pregnant should not handle the solution; Known hypersensitivity to finasteride.
Finasteride
Too few graded studiesPrescription drugFinasteride is a prescription medicine for male pattern hair loss and benign prostatic hyperplasia; the appropriate formulation and regimen depend on the indication. Sexual adverse effects can occur, and persistent symptoms have been reported. EU regulators confirmed suicidal thoughts as a side effect of oral finasteride, with unknown frequency. It is not a longevity treatment.
Minoxidil (oral & topical)
Too few graded studiesPrescription drugMinoxidil is a medicine used in topical formulations for certain hair-loss indications. Oral use for hair loss is off-label and requires a prescriber. Oral exposure can cause systemic cardiovascular adverse effects; a “low-dose” description does not make those effects uniformly mild.
Dutasteride
Too few graded studiesPrescription drugA dual 5α-reductase (type I + II) inhibitor approved for benign prostatic hyperplasia and used off-label for male pattern hair loss. It suppresses DHT more deeply than finasteride (which blocks only type II), and at 2.5 mg (five times the approved dose) it beat finasteride for hair count in one 24-week trial. It carries the same sexual and mood side-effect concerns as finasteride — with a much longer half-life, so any persistent effects clear more slowly. A prescription drug, not a supplement, and not a longevity drug.
Adapalene
Too few graded studiesOTC medicineA modern topical retinoid for acne — now available over the counter (0.1%) as well as by prescription (0.3%). A drug, not a supplement or cosmetic. Adapalene is a third-generation retinoid selective for the retinoic-acid receptor beta; it normalizes how skin cells shed (comedolytic) and is anti-inflammatory. The honest framing: this is one of the best-evidenced acne treatments — a 5-trial meta-analysis and a 40-trial network meta-analysis show it matches tretinoin's efficacy with faster onset and notably better tolerability, and the adapalene-benzoyl peroxide combination is among the most effective regimens available. Caveats: it still causes retinoid irritation and slow onset, it is not superior to (only as good as) other retinoids, and — as a retinoid — it is generally avoided in pregnancy.
Explore: Best supplements for Skin, Hair & Beauty
Edited by Dr. Baher Al Hakim · Last updated November 2026 · evidence from 8 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.